In this study, we demonstrate the potential of Brome mosaic virus-derived virus like particles (BMV-VLPs), as a biocompatible siRNA carrier for silencing PD-L1, a key immune checkpoint, in melanoma cells. The gene discussed is CD274; the disease is melanoma.